Traditional Chinese medicine composition for treating hyperplasia of mammary glands

Abstract

The invention discloses a traditional Chinese medicine composition for treating hyperplasia of mammary glands, which comprises the following traditional Chinese medicine raw materials by weight ratio: 10-20 parts of radix bupleuri, 10-20 parts of Chinese angelica, 10-20 parts of radix paeoniae rubrathe, 10-30 parts of Poria cocos, 5-20 parts of bighead atractylodes rhizome, 5-15 parts of mint, 10-20 parts of curcuma tuber, 10-20 parts of curcuma rhizome, 10-20 parts of tangerine seed, 10-20 parts of cowherb seed, 5-10 parts of green tangerine peel, 5-15 parts of Cyperus Rotundus L, 5-15 parts of oyster, 10-30 parts of alga, 10-20 parts of frankincense and 20-30 parts of myrrh. Through multi-time experiments and strict contrast, the above medicinal materials enables scientific compatibility according to respective function, the traditional Chinese medicine composition has effects of relieving liver for smoothing Qi, and eliminating phlegm and stagnant blood, can effectively treat hyperplasia of mammary glands, has the advantages of no toxic and side effect, safety and reliability, and low cost; resource of multiple medicinal materials is abundant, the traditional Chinese medicine composition can be decocted by water, the usage method is simple and convenient, and the drug effect is obvious.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating mammary gland hyperplasia. Background technique [0002] Breast hyperplasia is the most common breast disease in women, and its incidence rate accounts for the first place in breast diseases. In recent years, the incidence of the disease has been increasing year by year, and the age is getting younger and younger. Mammary gland hyperplasia is the physiological hyperplasia and incomplete involution of normal mammary gland lobules, and the normal structure of the mammary gland is disordered. It belongs to pathological hyperplasia. It is neither an inflammation nor a tumor. It mostly occurs in women aged 30-50, and the peak incidence is 35-40 years old. At present, there are many kinds of drugs for the treatment of mammary gland hyperplasia, but they are all palliatives, not the root cause. Patients often take the ...

AI Technical Summary

Problems solved by technology

At present, there are many kinds of drugs for the treatment of mammary gland hyperplasia, but they are all palliatives, not the root cause. Patients often take the drugs but do not get better, or they are good and bad, which brings many troubles to the life and work of the patients.